▶ 調査レポート

世界の医薬品&化粧品用偽造防止包装市場(~2027):技術別、エンドユーザー別、地域別

• 英文タイトル:Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market Research Report by Technology, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の医薬品&化粧品用偽造防止包装市場(~2027):技術別、エンドユーザー別、地域別 / Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market Research Report by Technology, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2301B085資料のイメージです。• レポートコード:MRC2301B085
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、235ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:包装
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の当調査資料では、2021年に539.4億ドルであった世界の医薬品&化粧品用偽造防止包装市場規模が、2022年に625.1億ドルに達し、2027年には年平均成長率16.06%で1,318.7億ドルまで拡大すると予測しています。当書は、医薬品&化粧品用偽造防止包装の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別(バーコード、フォレンジックマーカー、ホログラム、RfId、タンパーエビデント技術)分析、エンドユーザー別(アパレル&フットウェア、自動車、化粧品&パーソナルケア、電気&電子、食品&飲料)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などを整理しております。なお、当書には、3M Company、Abbey Labels、Alien Technology Corp.、Alpvision SA、Ampacet Corporation、Applied DNA Sciences、Arjo Solutions、ATL Security Label Systems、Authentix Inc.、Avery Dennison Corp.、Bayer AG、CCL Industries Inc.などの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界の医薬品&化粧品用偽造防止包装市場規模:技術別
- 医薬品&化粧品用偽造防止バーコードの市場規模
- 医薬品&化粧品用偽造防止フォレンジックマーカーの市場規模
- 医薬品&化粧品用偽造防止ホログラムの市場規模
- 医薬品&化粧品用偽造防止RfIdの市場規模
- 医薬品&化粧品用偽造防止タンパーエビデント技術の市場規模

・世界の医薬品&化粧品用偽造防止包装市場規模:エンドユーザー別
- アパレル&フットウェアにおける市場規模
- 自動車における市場規模
- 化粧品&パーソナルケアにおける市場規模
- 電気&電子における市場規模
- 食品&飲料における市場規模

・世界の医薬品&化粧品用偽造防止包装市場規模:地域別
- 南北アメリカの医薬品&化粧品用偽造防止包装市場規模
アメリカの医薬品&化粧品用偽造防止包装市場規模
カナダの医薬品&化粧品用偽造防止包装市場規模
ブラジルの医薬品&化粧品用偽造防止包装市場規模

- アジア太平洋の医薬品&化粧品用偽造防止包装市場規模
日本の医薬品&化粧品用偽造防止包装市場規模
中国の医薬品&化粧品用偽造防止包装市場規模
インドの医薬品&化粧品用偽造防止包装市場規模
韓国の医薬品&化粧品用偽造防止包装市場規模
台湾の医薬品&化粧品用偽造防止包装市場規模

- ヨーロッパ/中東/アフリカの医薬品&化粧品用偽造防止包装市場規模
イギリスの医薬品&化粧品用偽造防止包装市場規模
ドイツの医薬品&化粧品用偽造防止包装市場規模
フランスの医薬品&化粧品用偽造防止包装市場規模
ロシアの医薬品&化粧品用偽造防止包装市場規模

- その他地域の医薬品&化粧品用偽造防止包装市場規模

・競争状況
・企業情報

The Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market size was estimated at USD 53.94 billion in 2021 and expected to reach USD 62.51 billion in 2022, and is projected to grow at a CAGR 16.06% to reach USD 131.87 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the market was studied across Barcodes, Forensic Markers, Holograms, Overt, Covert, & Forensic Features, RfId, Serialization/Track & Trace Technologies, Tammass Encoding, and Tamper-Evident Technology. The Barcodes is further studied across Digital Mass Encryption and Digital Mass Serialization.

Based on End User, the market was studied across Apparel & Footwear, Automotive, Cosmetics & Personal Care, Electrical & Electronics, Food & Beverage, Luxury Goods, and Pharmaceutical.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market, including 3M Company, Abbey Labels, Alien Technology Corp., Alpvision SA, Ampacet Corporation, Applied DNA Sciences, Arjo Solutions, ATL Security Label Systems, Authentix Inc., Avery Dennison Corp., Bayer AG, CCL Industries Inc., CFC International, Inc, Datamax-O’Neil Corporation, Digimarc Corporation, DuPont de Nemours, Inc., Flint Group Corp., Impinj Inc., Inksure Technologies Inc., Intelligent Label Solutions, Label Makers Pty Ltd., OpSec Security Inc., PharmaSecure, Sicpa Holding S.A., Uflex Limited, and Zebra Technologies Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?
4. What is the competitive strategic window for opportunities in the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?
5. What are the technology trends and regulatory frameworks in the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?
6. What is the market share of the leading vendors in the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?
7. What modes and strategic moves are considered suitable for entering the Global Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth of the anti-counterfeit pharmaceutical and cosmetic packaging
5.1.1.2. Favorable laws & regulations by government intervention
5.1.2. Restraints
5.1.2.1. Expensive implementation of anti-counterfeiting technology
5.1.3. Opportunities
5.1.3.1. Advancement in technologies such as RFID technologies, track & trace technology, serialization, and barcodes scanners to streamline the supply chain process
5.1.3.2. Growing adoption of covert & overt technology
5.1.4. Challenges
5.1.4.1. Concerns with packaging market due to poor regulation and higher number of intermediates
5.2. Cumulative Impact of COVID-19

6. Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market, by Technology
6.1. Introduction
6.2. Barcodes
6.3.1. Digital Mass Encryption
6.3.2. Digital Mass Serialization
6.3. Forensic Markers
6.4. Holograms
6.5. Overt, Covert, & Forensic Features
6.6. RfId
6.7. Serialization/Track & Trace Technologies
6.8. Tammass Encoding
6.9. Tamper-Evident Technology

7. Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market, by End User
7.1. Introduction
7.2. Apparel & Footwear
7.3. Automotive
7.4. Cosmetics & Personal Care
7.5. Electrical & Electronics
7.6. Food & Beverage
7.7. Luxury Goods
7.8. Pharmaceutical

8. Americas Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. 3M Company
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Abbey Labels
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Alien Technology Corp.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Alpvision SA
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Ampacet Corporation
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Applied DNA Sciences
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Arjo Solutions
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. ATL Security Label Systems
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Authentix Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Avery Dennison Corp.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Bayer AG
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. CCL Industries Inc.
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. CFC International, Inc
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Datamax-O’Neil Corporation
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Digimarc Corporation
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. DuPont de Nemours, Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. Flint Group Corp.
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Impinj Inc.
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Inksure Technologies Inc.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Intelligent Label Solutions
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. Label Makers Pty Ltd.
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. OpSec Security Inc.
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. PharmaSecure
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Sicpa Holding S.A.
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services
12.25. Uflex Limited
12.25.1. Business Overview
12.25.2. Key Executives
12.25.3. Product & Services
12.26. Zebra Technologies Corporation
12.26.1. Business Overview
12.26.2. Key Executives
12.26.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing